SCHEMBL7312102

SCHEMBL7312102

COc1cc2c(C)nc(O)c(C(C)C)c2cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.46
PDE3A Q14432 3/20 0.46
KDM4E B2RXH2 4/20 0.44
RAC1 P63000 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
PDE10A Q9Y233 5/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 2/20 0.37
PDE4A P27815 1/20 0.37
PDE4D Q08499 1/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7317441 0.83 KDM4E (0.39) PDE3BPDE3AKDM4ERAC1MEN1
SCHEMBL7305960 0.82 KDM4E (0.38) PDE3BPDE3AKDM4ERAC1MEN1
SCHEMBL6313239 0.79 KDM4E (0.49) PDE3BPDE3AKDM4ERAC1MEN1
SCHEMBL7309710 0.76 KDM4E (0.46) PDE3BPDE3AKDM4ERAC1MEN1
SCHEMBL7434923 0.76 KDM4E (0.46) KDM4ERAC1MEN1KMT2APOLB
SCHEMBL7308411 0.76 KDM4E (0.46) PDE3BPDE3AKDM4ERAC1MEN1
Bromide SCHEMBL7318711 0.73 KDM4E (0.47) PDE3BPDE3AKDM4ERAC1MEN1
SCHEMBL7318410 0.73 PDE3B (0.46) PDE3BPDE3AKDM4ERAC1MEN1
SCHEMBL12325390 0.72 CYP3A4 (0.46) PDE3BPDE3AKDM4ERAC1MEN1
Hydrochloric Acid SCHEMBL27947697 0.72 KDM4E (0.46) PDE3BPDE3AKDM4ERAC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US claimed